B LYNNE PARSHALL
CIK 1073385 · COO · last filed 2026-06-25
B LYNNE PARSHALL is a COO who has filed 188 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for FHTX, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$93.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.12M
7
188
-$93.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Director | — | $6.07 | — | $0 | 5 | 2026-06-25 |
| CYTK | Director | 15,784 | $76.76 | $1.21M | -$7.72M | 38 | 2026-06-01 |
| IONS | Director | 51,344 | $56.56 | $2.90M | -$17.94M | 43 | 2026-04-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Director | — | — | — | $0 | 5 | 2020-10-13 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | COO & Secretary | 13,143 | — | — | -$24.74M | 59 | 2015-11-09 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 104,715 | $8.16 | $854.5K | -$42.66M | 17 | 2014-11-05 |
| CARDIODYNAMICS INTERNATIONAL CORP (CDIC) Delisted | Director | 0 | — | — | $0 | 4 | 2009-08-14 |
Recent Filings
188 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | CYTK | Sell (S) | −5,000 | -$370.4K | EDGAR |
| 2026-05-27 | CYTK | Grant (A) | +2,851 | $0 | EDGAR |
| 2026-04-17 | IONS | Sell (S) | −5,000 | -$381.4K | EDGAR |
| 2026-03-02 | CYTK | Notice (144) | −10,000 | -$622.2K | EDGAR |
| 2026-03-02 | CYTK | Sell (S) | −5,000 | -$306.1K | EDGAR |
| 2026-02-13 | IONS | Sell (S) | −5,000 | -$413.6K | EDGAR |
| 2026-02-11 | IONS | Notice (144) | −10,000 | -$827.4K | EDGAR |
| 2025-11-19 | CYTK | Notice (144) | −5,000 | -$330.8K | EDGAR |
| 2025-11-19 | CYTK | Sell (S) | −5,000 | -$323.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.